gabapentin

Product NDC: 16571-868
11-digit product format: 165710868
Labeler code: 16571
Product ID: 16571-868_2e493243-47c0-460e-bea9-4ed0261adf90
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: gabapentin
Dosage form: CAPSULE
Route: ORAL
Labeler: Rising Pharma Holdings, Inc.
Application: ANDA207099
Marketing category: ANDA
Marketing start: 2022-08-01
Substance: GABAPENTIN
Active strength: 300 mg/1
Pharmacologic classes: Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A207099-001	GABAPENTIN	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2017-03-24
A207099-002	GABAPENTIN	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2017-03-24
A207099-003	GABAPENTIN	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2017-03-24

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A207099-001	AB
A207099-002	AB
A207099-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A207099-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2017-03-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207099-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2017-03-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207099-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2017-03-24	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207099-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2017-03-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207099-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2017-03-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207099-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2017-03-24	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A207099-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2017-03-24	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A207099-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2017-03-24	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A207099-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2017-03-24	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A207099-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2017-03-24	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A207099-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2017-03-24	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A207099-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2017-03-24	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A207099-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2017-03-24	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A207099-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2017-03-24	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A207099-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2017-03-24	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A207099-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2017-03-24	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A207099-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2017-03-24	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A207099-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2017-03-24	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A207099-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2017-03-24	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A207099-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2017-03-24	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A207099-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2017-03-24	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207099-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2017-03-24	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207099-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2017-03-24	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207099-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2017-03-24	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A207099-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2017-03-24	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A207099-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2017-03-24	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A207099-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2017-03-24	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A207099-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2017-03-24	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A207099-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2017-03-24	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A207099-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2017-03-24	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A207099-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2017-03-24	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A207099-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2017-03-24	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A207099-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2017-03-24	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A207099-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2017-03-24	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A207099-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2017-03-24	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A207099-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2017-03-24	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A207099-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2017-03-24	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A207099-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2017-03-24	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A207099-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2017-03-24	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A207099-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2017-03-24	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A207099-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207099-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207099-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207099-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207099-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207099-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A207099-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A207099-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A207099-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A207099-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A207099-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A207099-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A207099-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A207099-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A207099-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A207099-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A207099-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A207099-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A207099-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A207099-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A207099-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207099-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207099-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207099-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A207099-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A207099-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A207099-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A207099-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A207099-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A207099-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A207099-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A207099-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A207099-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A207099-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A207099-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A207099-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A207099-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A207099-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A207099-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A207099-001	AB	1	`8072bd15b7f6…`

Additional Listing Data#

Finished product: Yes
Brand name base: gabapentin
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
GABAPENTIN	300 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
6CW7F3G59X	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
310430	Internal RxNorm lookup
310431	Internal RxNorm lookup
310432	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
969cccfc-e56a-49da-9d36-47c0c3fad7f8	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
cdc2ae60-922e-452d-a42f-787fe4e2ed06	Product name	1	20250123
7059096a-4b9f-36c2-db50-bb5c723e6e9e	Product name	2	20250114
6c13b22c-b3ba-4127-b768-0132dd5ab0d1	Product name	1	20230829
fa3f0129-3502-889f-f424-3a37727959e7	Product name	9	20181206
77d89e4c-f57f-326d-d7aa-787f8eebbd2b	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
16571-868-01	gabapentin	100 in 1 BOTTLE	CAPSULE	100	3
16571-868-03	gabapentin	30 in 1 BOTTLE	CAPSULE	30	3
16571-868-10	gabapentin	1000 in 1 BOTTLE	CAPSULE	1000	3
16571-868-50	gabapentin	500 in 1 BOTTLE	CAPSULE	500	3

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
16571-868-01	EA - Each	16571-868	556b71b2-bdb3-45aa-9562-ed7d6de2a315	1	2022-08-04
16571-868-10	EA - Each	16571-868	e36200fe-2856-49c8-a813-d5624f79ac5b	1	2022-08-04
16571-868-50	EA - Each	16571-868	4b586652-6755-44e2-93b8-d520fed89c8f	1	2022-08-04

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
16571-868	GABAPENTIN CAPSULE [RISING PHARMA HOLDINGS, INC.]	2	Current NDC, Legacy NDC, 4 package rows	20250529_969cccfc-e56a-49da-9d36-47c0c3fad7f8.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 12 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
gabapentin	GABAPENTIN	REMEDYREPACK INC.	32169228-e85c-4dbf-8722-cd2f8e0f5d1a	2026-07-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 207099 application number: ANDA207099
Gabapentin	GABAPENTIN	St. Mary's Medical Park Pharmacy	2bc65375-77b8-1e50-e063-6294a90acf8f	2026-06-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 207099 application number: ANDA207099
gabapentin	GABAPENTIN	Proficient Rx LP	c7674ea5-276b-4bb3-821b-4ac05c9e64e6	2026-06-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 207099 application number: ANDA207099
Gabapentin	GABAPENTIN	Direct_Rx	0b286fd1-8179-d87a-e063-6294a90a2f23	2026-03-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 207099 application number: ANDA207099
gabapentin	GABAPENTIN	Coupler LLC	47cd25f6-e123-9aaf-e063-6394a90aeedd	2026-01-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 207099 application number: ANDA207099
gabapentin	GABAPENTIN	Northwind Health Company, LLC	471b2d32-0cbd-aade-e063-6394a90a1696	2025-12-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 207099 application number: ANDA207099
gabapentin	GABAPENTIN	REMEDYREPACK INC.	4a975ebe-ae0a-446a-8a3d-2ca325e28f93	2025-09-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 207099 application number: ANDA207099
gabapentin	GABAPENTIN	Coupler LLC	3eeda97d-c3cd-65cd-e063-6394a90aae8b	2025-09-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 207099 application number: ANDA207099
Gabapentin	GABAPENTIN	Direct_Rx	2cb1ad6d-d389-4564-e063-6394a90a3644	2025-08-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 207099 application number: ANDA207099
gabapentin	GABAPENTIN	Rising Pharma Holdings, Inc.	969cccfc-e56a-49da-9d36-47c0c3fad7f8	2025-06-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 207099 application number: ANDA207099 ndc (product): 16571-868
Gabapentin	GABAPENTIN	Proficient Rx LP	64a65366-8577-48f2-9f8e-0332f126d3c1	2025-03-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 207099 application number: ANDA207099
Gabapentin	GABAPENTIN	Epic Pharma, LLC	030e656a-e384-49ac-830f-32140c18112d	2019-01-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 207099 application number: ANDA207099

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6CW7F3G59X	GABAPENTIN	60142-96-3	GABAPENTIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
310431	gabapentin 300 MG Oral Capsule	PSN	2bc65375-77b8-1e50-e063-6294a90acf8f	4
310431	gabapentin 300 MG Oral Capsule	PSN	2cb1ad6d-d389-4564-e063-6394a90a3644	4
310431	gabapentin 300 MG Oral Capsule	SCD	2bc65375-77b8-1e50-e063-6294a90acf8f	4
310431	gabapentin 300 MG Oral Capsule	SCD	2cb1ad6d-d389-4564-e063-6394a90a3644	4
310430	gabapentin 100 MG Oral Capsule	PSN	969cccfc-e56a-49da-9d36-47c0c3fad7f8	3
310431	gabapentin 300 MG Oral Capsule	PSN	969cccfc-e56a-49da-9d36-47c0c3fad7f8	3
310432	gabapentin 400 MG Oral Capsule	PSN	969cccfc-e56a-49da-9d36-47c0c3fad7f8	3
310430	gabapentin 100 MG Oral Capsule	SCD	969cccfc-e56a-49da-9d36-47c0c3fad7f8	3
310431	gabapentin 300 MG Oral Capsule	SCD	969cccfc-e56a-49da-9d36-47c0c3fad7f8	3
310432	gabapentin 400 MG Oral Capsule	SCD	969cccfc-e56a-49da-9d36-47c0c3fad7f8	3
310431	gabapentin 300 MG Oral Capsule	PSN	471b2d32-0cbd-aade-e063-6394a90a1696	2
310431	gabapentin 300 MG Oral Capsule	SCD	471b2d32-0cbd-aade-e063-6394a90a1696	2
310431	gabapentin 300 MG Oral Capsule	PSN	64a65366-8577-48f2-9f8e-0332f126d3c1	1
310431	gabapentin 300 MG Oral Capsule	SCD	64a65366-8577-48f2-9f8e-0332f126d3c1	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
16571-868-01	16571086801	100 CAPSULE in 1 BOTTLE (16571-868-01)	100 capsule	2022-08-01	0000-00-00	No	No	Current
16571-868-03	16571086803	30 CAPSULE in 1 BOTTLE (16571-868-03)	30 capsule	2022-08-01	0000-00-00	No	No	Current
16571-868-10	16571086810	1000 CAPSULE in 1 BOTTLE (16571-868-10)	1000 capsule	2022-08-01	0000-00-00	No	No	Current
16571-868-50	16571086850	500 CAPSULE in 1 BOTTLE (16571-868-50)	500 capsule	2022-08-01	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Gabapentin	St. Mary's Medical Park Pharmacy	2026-06-26	HUMAN PRESCRIPTION DRUG LABEL	5
gabapentin	Coupler LLC \| Rising Pharma Holdings, Inc.	2026-01-07	HUMAN PRESCRIPTION DRUG LABEL	1
gabapentin	Northwind Health Company, LLC	2025-12-29	HUMAN PRESCRIPTION DRUG LABEL	2
Gabapentin	Direct_Rx	2025-08-19	HUMAN PRESCRIPTION DRUG LABEL	4
gabapentin	Rising Pharma Holdings, Inc. \| Graviti Pharmaceuticals Private Limited	2025-06-03	HUMAN PRESCRIPTION DRUG LABEL	3
Gabapentin	Proficient Rx LP	2025-03-01	HUMAN PRESCRIPTION DRUG LABEL	1